Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 Industry Snapshot
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Value of Health
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Workforce Training Center at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Week 2022
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Discovery Life Sciences, LLC

Life Sciences | Research Products & Instrumentation
Malden, MA 781-397-9300 Website

Overview

IVAL is proud to present our products and contract services, which represent three decades of expertise in the application of in vitro experimental systems to evaluate drug absorption, metabolism, drug-drug interactions and drug toxicity. Our forte: high-quality hepatocytes and cell culture media to support in vitro research.

In addition to the “routine” in vitro ADME studies that are offered by many contract research organizations, we have developed techniques that allow the use of hepatocytes in higher throughput screening assays to aid the selection of best drug candidates for during early phases of drug development: Organ-specific toxicity evaluation (e.g. hepatotoxicity; nephrotoxicity; neurotoxicity) using primary cells either as mono-cell type studies or as multiple organ co-cultures using our patented Integrated Discrete Multiple Organ Co-culture (IdMOC) experimental system; human hepatocyte P450 inhibition assays, and human hepatocyte P450 induction assays; as well as a comprehensive screening assay for adverse drug properties..

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2023 All Rights Reserved